Duodenoscopes Market Research Report Information: By Types, (Rigid Duodenoscopes and Flexible Duodenoscopes), Application, (Diagnosis and Treatment), End User (Gastrologists, General and Pediatric Surgeons, Hospitals, Speciality Clinics, and Others) - Forecast till 2032

Duodenoscopes Market Overview

Duodenoscopes Market Size was valued at USD 99.29 Billion in 2023. The Global Duodenoscopes industry is projected to grow from USD 107.44 Billion in 2024 to USD 207.03 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.34% during the forecast period (2024 - 2032). Duodenoscope is a flexible, lighted weighted tubes that are released through the mouth, throat, and stomach into the top of the small intestine. These are specially designed side-viewing endoscope for endoscopic retrograde cholangiopancreatography (ERCP) procedures, which will help to diagnose diseases associated with pancreas and bile ducts with the help of fluoroscopic imaging procedure.

On May 17, 2023, a firm that pioneers in making lab and clinical solutions for Roche Information Solutions India Pvt. Ltd. held “Innovation Past, Present and Future”– showcasing innovative laboratory solutions and digital diagnostics at WorldLab-EuroMedLab 2023 in Rome, Italy, from May 21-25th,2023. People had an opportunity to see the latest advancements of Roche in its lab automation, serum work area, molecular and point of care solutions through experiences, as well as know more about how it is transforming patient care by finding new ways with breakthrough high medical value diagnostic and digital solutions.

In January 2022, Wassenburg Medical B.V., a company providing endoscope reprocessing products and services in the U.S., announced that it had bought Custom Ultrasonics, an American medical equipment manufacturer. This acquisition will create additional growth in the US market for both companies.

Al Jalila Foundation raised AED220 million $59.88 million) for Hamdan Bin Rashid Cancer Charity Hospital in August 2021. This hospital accepts patients from anywhere in the UAE, and all services will be highly subsidized or free of charge. Such initiatives promote the adoption of duodenoscopes to respective cancer treatments, thereby supporting Middle East market growth.

Medanta introduced single-use duodenoscope technology for advanced bile and pancreatic treatments in February 2021. Medanta launched a disposable duodenoscope treatment for common bile duct stones, tumors, infections, inflammation, and pancreatic duct stones.

The Ambu Company, which develops, manufactures, and markets such devices as diagnostic devices, life-supporting devices for hospitals, and rescue services across North America, announced the receipt of U.S.FDA’s (510(k)) clearance for aScope Duodeno in July 2020.

Ambu Inc. got 510(k) regulatory clearance from the USA Food and Drug Administration (FDA) in July 2022 on its new sterile bronchoscopes called Ambu aScope 5 Broncho, which is now in its fifth generation.

For its Hamdan Bin Rashid Cancer Charity Hospital, the Al Jalila Foundation raised AED220 million ($59.88 million) in August 2021. This service can be accessed by anyone within the UAE and all treatments done there will be subsidized or even free of charge; this is a campaign for cancer patients who can benefit from duodenoscope as well as increase market demand in Middle East countries.

In May 2021, PENTAX Medical Europe announced that they received a CE marking for their brand-new single-use bronchoscope known as PENTAX Medical ONE Pulmo. This groundbreaking product delivers high-quality pulmonary care. It is a disposable bronchoscope with enhanced suction power and high-resolution images.

Medanta introduced single-use duodenoscope technology for advanced bile and pancreatic treatments in February 2021. Medanta launched a disposable duodenoscope treatment for common bile duct stones, tumours, infections, inflammation, and pancreatic duct stones.

Olympus informed about the launch of the New TJF-Q190V Duodenoscope at the United States’ levels last June 2020. The latest duodenoscope represents an improvement on previous Olympus models, featuring better visuals as well as improved ERCP maneuverability (Endoscopic Retrograde Cholangiopancreatography). The TJF-Q190V duodenoscope contains safety features aimed at improving reprocessing efficiency, such as a manual flushing adapter and disposable distal cover.

Olympus announced in June 2020 the availability of the New TJF-Q190V Duodenoscope in the United States. The TJF-Q190V duodenoscope includes safety features meant to enhance the efficiency of reprocessing together with a manual flushing adapter and disposable distal cover.

Duodenoscope is a more complex device as compared to other endoscopes and is tough to clean and disinfect. These devices play an essential role in the treatment of patients, but there has been some evidence, which showed that some patients were infected with hospital born and other infectious agents, including antibiotic drug-resistant infections due to these devices. In 2013, the Centers for Disease Control and Prevention (CDC) alerted the FDA regarding possible association of multidrug-resistant bacterial infections and duodenoscopes. ERCP was associated with infections in 135 patients from January 2013 to December 2014. 

The duodenoscopes market is growing moderately due to the increasing prevalence of pancreatic, bile duct cancer tumors, and various gastrointestinal. Additionally, increasing research and development, technological advancements to identify the causes and risk factors associated with transmission of infectious agents from duodenoscopes, and developing new solutions to minimize patient exposure to such infection likely to drive the market growth over the review period.

According to the latest WHO report (World Health Organization), in 2015, 8.8 million people died across the globe from cancer, which is nearly 1 in 6 of all the global deaths. According to the WHO, approximately 70% of deaths from cancer occur in low- and middle-income countries. Moreover, according to a report by the World Gastroenterology Organization, (2014), 35-40% of the world’s total population had acute or chronic GI complications.

However, increasing FDA recalls for duodenoscopes due to challenging cleaning and high-level disinfection procedures and rising multidrug-resistant bacterial infections may affect the growth of the duodenoscopes market negatively.

Duodenoscopes Market Segmentation

The duodenoscopes market is segmented on the basis of types, application, and end user.

On the basis types

Duodenoscopes market is segmented into rigid duodenoscopes and flexible duodenoscopes. The flexible duodenoscopes is further segmented into fiber-optic duodenoscope and video duodenoscope.

On the basis of application

Duodenoscopes market is segmented into diagnosis and treatment. The diagnosis is further segmented into detect abberations, trauma or surgical complications in bile or pancreatic ducts, tumors or cancers of the bile ducts, inflammation of the pancreas, chronic pancreatitis, pancreatic pseudocysts, and tumors or cancers of the pancreas. The detect abberations is further segmented into bile duct, cystic duct, hepatic ducts, and pancreatic ducts. Treatment is further segmented into cannulation, sphincterotomy, stone management, and drainage of the bile duct.

On the basis of end user

Duodenoscopes market is segmented into gastrologists, general and pediatric surgeons, hospitals, speciality clinics, and others. 

Key Players

• FUJIFILM Holdings Corporation


• KARL STORZ GmbH & Co. KG


• PENTAX Medical


• Olympus Corporation


• Custom Ultrasonics, Inc.


• ENDOMED


• SonoScape

 Regional Analysis

The Americas dominates the duodenoscopes market owing to the presence of strong economic condition, huge development in the healthcare domain, and focus of research institutions on updating technology for new and advanced diagnosis and treatment methods. Moreover, advanced hospitals infrastructures, and availability of skilled healthcare professional adding fuel to the growth of the duodenoscopes market.

Europe holds the second position in the market on the basis of increasing emphasis on rapid diagnosis and treatment of cancer, and gastrointestinal diseases, changing lifestyle, increasing prevalence of cancer among geriatric population. As per Organization for Economic Co-operation and Development (OECD), Germany spent 11% of the total GDP on healthcare in 2013, which was 10.8% in 2012, which drives the growth of the duodenoscopes market in this region. 

Asia Pacific is the fastest growing market owing to more number of developing nations present in this region, for instance, countries like India and china. These countries are encouraging the growth of the healthcare domain. Furthermore, increasing patient population from cancer and gastrointestinal diseases in developing countries will directly increase the demand for various diagnosis & treatment methods, which, in turn, will boost the growth of the duodenoscopes market.    

The Middle East & Africa is expected to hold the least market share due to less availability of medical facilities, and less development in the healthcare domain. However, countries such as Qatar and Kuwait are focusing more on the healthcare domain and developing medical facilities, which will boost the duodenoscopes market of this region. 

Intended Audience

• Pharmaceutical Companies


• Medical Devices Companies


• Research and Development (R&D) Companies


• Market Research and Consulting Service Providers


• Potential Investors